Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection

By sjmartinez • February 25, 2025

Happe M, Lynch RM, Fichtenbaum CJ, Heath SL, Koletar SL, Landovitz RJ, Presti RM, Santana-Bagur JL, Tressler RL, Holman LA, Novik L, Roa JC, Rothwell RS, Strom L, Wang J, Hu Z, Conan-Cibotti M, Bhatnagar AM, Dwyer B, Ko SH, Belinky F, Namboodiri AM, Pandey JP, Carroll R, Basappa M, Serebryannyy L, Narpala SR, Lin BC, McDermott AB, Boritz EA, Capparelli EV, Coates EE, Koup RA, Ledgerwood JE, Mascola JR, Chen GL, Tebas P; VRC 607/A5378 Study Team. Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection. JCI Insight. 2025 Feb 24;10(4):e181496. doi: 10.1172/jci.insight.181496. PMID: 39989458.

Tags: AIDS/HIV, clinical trials, drug therapy, Infectious Diseases, Publications

Related Posts

Unintentional Fentanyl Use Detected in Hair of People With HIV Risk Using Methamphetamine

Appa A, Spinelli MA, Javanbakht M, Heise MJ, Okochi H, Bazazi AR, Coffin P, Gorbach PM, Gandhi M. Unintentional Fentanyl Use Detected in Hair of[...]

From pregnancy to beyond: renewed emphasis on comprehensive HIV prevention in South Africa

Babalola CM, Peters RPH, Muzny CA, Davey DJ, Taylor CM, Mdingi MM, Mukomana F, de Vos L, Medina-Marino A, Klausner JD. From pregnancy to beyond:[...]

Assessing coronavirus disease 2019 pandemic impacts on the health of people who inject drugs using a novel data sharing model

Bradley H, Luisi N, Carter A, Pigott TD, Abramovitz D, Allen ST, Asher A, Austin C, Bartholomew TS, Baum M, Board A, Boodram B, Borquez[...]